Insider · CIK 0001070600

STOUGHTON W. VICKERY

Reports to the SEC for 2 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001070600

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-03-11	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+19.4K sh	—	—	53,574
2014-03-11	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−4,838 sh	$3.65	−$17.7K	48,736
2014-03-11	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	−19.4K sh	—	—	0
2013-06-13	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+16K sh	—	—	16,042
2013-06-09	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−1,135 sh	$1.86	−$2,111.1	34,222
2012-06-07	Cascadian Therapeutics, Inc.A Award	Director	AAward	+8,174 sh	$3.67	+$30K	35,357
2012-06-03	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−2,021 sh	$3.51	−$7,093.71	27,183
2012-05-03	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+989 sh	—	—	29,451
2012-05-03	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−247 sh	$4.15	−$1,025.05	29,204
2012-05-03	Cascadian Therapeutics, Inc.Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−989 sh	—	—	0
2011-12-31	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−597 sh	$7.58	−$4,525.26	28,462
2011-12-31	Cascadian Therapeutics, Inc.Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,388 sh	—	—	0
2011-12-31	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,388 sh	—	—	29,059
2011-12-04	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−1,546 sh	$6.86	−$10.6K	26,671
2011-06-12	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,076 sh	—	—	28,217
2011-06-12	Cascadian Therapeutics, Inc.Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,076 sh	—	—	0
2011-06-09	Cascadian Therapeutics, Inc.A Award	Director	AAward	+4,538 sh	—	—	26,141
2010-12-14	Cascadian Therapeutics, Inc.Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,166 sh	—	—	0
2010-12-14	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,166 sh	—	—	21,603
2010-06-03	Cascadian Therapeutics, Inc.A Award	Director	AAward	+8,086 sh	—	—	18,437
2009-12-04	Cascadian Therapeutics, Inc.A Award	Director	AAward	+6,185 sh	—	—	10,351
2009-03-11	Cascadian Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+21.4K sh	—	—	21,428
2009-03-11	Cascadian Therapeutics, Inc.Restricted Share UnitsA Award	Director	AAward	+19.4K sh	—	—	19,352
2000-07-12	CARESIDE INCP Purchase	Insider	PPurchase	+3,000 sh	$3.91	+$11.7K	300,505
2000-07-11	CARESIDE INCP Purchase	Insider	PPurchase	+5,000 sh	$3.90	+$19.5K	300,505
2000-06-20	CARESIDE INCP Purchase	Insider	PPurchase	+7,000 sh	$5.38	+$37.6K	292,505

Recent filings

Accepted (ET)
Mar 124
Oncothyreon Inc.0001209191-14-019886
SEC(opens sec.gov)
Jun 144
Oncothyreon Inc.0001209191-13-032267
SEC(opens sec.gov)
Jun 114
Oncothyreon Inc.0001209191-13-031629
SEC(opens sec.gov)
Jun 84
STOUGHTON W. VICKERY0001179110-12-009817
SEC(opens sec.gov)
Jun 54
STOUGHTON W. VICKERY0001179110-12-009676
SEC(opens sec.gov)
May 44
STOUGHTON W. VICKERY0001179110-12-007819
SEC(opens sec.gov)
Jan 34
STOUGHTON W. VICKERY0001179110-12-000034
SEC(opens sec.gov)
Dec 74
STOUGHTON W. VICKERY0001179110-11-016222
SEC(opens sec.gov)
Jun 134
STOUGHTON W. VICKERY0001209191-11-034367
SEC(opens sec.gov)
Dec 154
STOUGHTON W. VICKERY0001412067-10-000005
SEC(opens sec.gov)
Jun 44
STOUGHTON W. VICKERY0001418872-10-000002
SEC(opens sec.gov)

Companies

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121